Predicting how a biotherapeutic will behave in humans is a critical step in drug design —but it's far from straightforward. While nonclinical models can help foresee certain negative effects, they often fall short when it comes to immunotoxicity and other immune-related reactions. With the g
Artificial intelligence (AI) is increasingly becoming embedded in the fabric of modern medicine, creating significant changes in how healthcare professionals deliver patient care. The adoption of AI technologies has ushered in a new era where AI acts akin to a "super smart assistant,
Telemedicine has revolutionized healthcare delivery, enabling clinicians to prescribe medications remotely. This paradigm shift, while enhancing patient access to care, also introduces distinct challenges that providers must navigate to ensure effective treatment. Successful long-term telemedicine
Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing
The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among
Ivan Kairatov is a Biopharma expert with a deep knowledge of technology and innovation in the industry and extensive experience in research and development. In this interview, we delve into the topic of refget Sequence Collections, a new tool developed to increase the efficiency of genomic
Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve
Verve Therapeutics has announced a significant advancement in genetic medicine as their investigational drug VERVE-102 receives Fast Track designation from the U.S. Food and Drug Administration (FDA). This approval marks a crucial step in the development of treatments for hyperlipidemia and
Addressing the pervasive issue of hearing loss in America, a new partnership between Health-E Commerce and Jabra Enhance aims to significantly improve access to affordable, high-quality hearing aids. This collaboration capitalizes on the benefits of telehealth and flexible spending accounts (FSAs)
The rapid advancements in telehealth have been met with a mixture of enthusiasm and concern, especially as regulatory frameworks struggle to keep pace with technological innovations. At the center of this challenge is Mehmet Oz, the newly appointed Administrator of the Centers for Medicare
